Karina Miranda Santiago

Variable population prevalence estimates of germline <i>TP53</i> variants: A gnomAD-based analysis

Kelvin C. de Andrade, Megan N. Frone, Talía Wegman-Ostrosky et al. · Human Mutation · 2018 · 95 citations · Full text

Medicine, Genetics, Molecular Genetics +17

XAF1 as a modifier of p53 function and cancer susceptibility

Emília M. Pinto, Bonald C. Figueiredo, Wenan Chen et al. · Science Advances · 2020 · 56 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study

Jung Kim, Matthew Gianferante, Danielle M. Karyadi et al. · JNCI Cancer Spectrum · 2021 · 47 citations · Full text

Medicine, Genetics, Oncology +17

Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls

Jung Kim, Wen Luo, Mingyi Wang et al. · Genome Medicine · 2018 · 31 citations · Full text

Life Sciences, Genetics, Oncology +17

Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation

Kelvin C. de Andrade, Karina Miranda Santiago, Lisley I. Mambelli et al. · Genetics and Molecular Biology · 2016 · 26 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17